These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15952486)
41. The menopausal hot flush--anything new? Sturdee DW Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981 [TBL] [Abstract][Full Text] [Related]
42. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Loprinzi CL; Barton DL; Sloan JA; Novotny PJ; Dakhil SR; Verdirame JD; Knutson WH; Kelaghan J; Christensen B Menopause; 2008; 15(4 Pt 1):655-60. PubMed ID: 18427355 [TBL] [Abstract][Full Text] [Related]
44. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms. Simon JA; Menopause; 2006; 13(2):222-31. PubMed ID: 16645536 [TBL] [Abstract][Full Text] [Related]
45. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. Goodwin JW; Green SJ; Moinpour CM; Bearden JD; Giguere JK; Jiang CS; Lippman SM; Martino S; Albain KS J Clin Oncol; 2008 Apr; 26(10):1650-6. PubMed ID: 18375894 [TBL] [Abstract][Full Text] [Related]
46. Comparative study of coitus and non-coitus in the treatment of menopausal symptoms. Akinwale SO Afr J Med Med Sci; 2007 Mar; 36(1):17-21. PubMed ID: 17874489 [TBL] [Abstract][Full Text] [Related]
47. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Buijs C; Mom CH; Willemse PH; Marike Boezen H; Maurer JM; Wymenga AN; de Jong RS; Nieboer P; de Vries EG; Mourits MJ Breast Cancer Res Treat; 2009 Jun; 115(3):573-80. PubMed ID: 18670875 [TBL] [Abstract][Full Text] [Related]
48. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831 [TBL] [Abstract][Full Text] [Related]
49. Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Carpenter JS; Monahan PO; Azzouz F Obstet Gynecol; 2004 Dec; 104(6):1322-6. PubMed ID: 15572497 [TBL] [Abstract][Full Text] [Related]
50. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA Menopause; 2006; 13(3):411-22. PubMed ID: 16735938 [TBL] [Abstract][Full Text] [Related]
51. Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin. Othman AH; Zaky AH Pain Med; 2014 Mar; 15(3):410-7. PubMed ID: 24423018 [TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408 [TBL] [Abstract][Full Text] [Related]
53. Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Reed SD; Mitchell CM; Joffe H; Cohen L; Shifren JL; Newton KM; Freeman EW; Larson JC; Manson JE; LaCroix AZ; Guthrie KA Obstet Gynecol; 2014 Aug; 124(2 Pt 1):233-241. PubMed ID: 25004335 [TBL] [Abstract][Full Text] [Related]
54. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215 [TBL] [Abstract][Full Text] [Related]
55. Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer--a prospective multicenter study with long-term follow-up. Frisk J; Spetz AC; Hjertberg H; Petersson B; Hammar M Eur Urol; 2009 Jan; 55(1):156-63. PubMed ID: 18294761 [TBL] [Abstract][Full Text] [Related]
56. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148 [TBL] [Abstract][Full Text] [Related]
57. Nonestrogenic management of hot flashes. Loprinzi CL; Barton DL; Qin R J Clin Oncol; 2011 Oct; 29(29):3842-6. PubMed ID: 21911722 [No Abstract] [Full Text] [Related]
58. [Management of hot flushes for breast cancer survivors]. Boutet G Gynecol Obstet Fertil; 2012 Apr; 40(4):241-54. PubMed ID: 22464746 [TBL] [Abstract][Full Text] [Related]
59. [Our experience in the treatment of climacteric complaints with Livial (Organon)]. Pekhlivanov B; Malinova M; Milchev N Akush Ginekol (Sofiia); 2001; 40(4):16-7. PubMed ID: 11803863 [TBL] [Abstract][Full Text] [Related]
60. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]